Isofol Medical AB (publ) announced that Thomas Andersson, at his own request, has chosen to resign as Chief Executive Officer of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.688 SEK | -2.96% | -3.78% | -5.75% |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-5.75% | 10.76M | |
+16.38% | 79.16B | |
+8.99% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B |
- Stock Market
- Equities
- ISOFOL Stock
- News Isofol Medical AB
- Isofol Medical AB Announces Resignation of Thomas Andersson as CEO